Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Clinical trial NCT00753272 · COMPLETED
Trial details
- NCT number
- NCT00753272
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-15
- Primary completion
- 2010-06-18
- Enrollment
- 43695
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.